These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 29524093)
1. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review. Martens B; De Pauw M; De Bleecker JL Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093 [TBL] [Abstract][Full Text] [Related]
2. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder]. Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239 [TBL] [Abstract][Full Text] [Related]
3. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
4. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Ikeda S; Nakazato M; Ando Y; Sobue G Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of familial amyloid polyneuropathy]. Adams D; Samuel D; Slama M Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949 [TBL] [Abstract][Full Text] [Related]
8. [The ocular involvement in the transthyretin-related familial amyloid polyneuropathy]. Lin HY; Dai RP Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):783-785. PubMed ID: 29050191 [TBL] [Abstract][Full Text] [Related]
10. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study. Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792 [TBL] [Abstract][Full Text] [Related]
12. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients. Ikeda S Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427 [TBL] [Abstract][Full Text] [Related]
13. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation. Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035 [TBL] [Abstract][Full Text] [Related]
14. Familial amyloid polyneuropathy. Planté-Bordeneuve V; Said G Lancet Neurol; 2011 Dec; 10(12):1086-97. PubMed ID: 22094129 [TBL] [Abstract][Full Text] [Related]
15. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina]. Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849 [TBL] [Abstract][Full Text] [Related]
16. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970 [TBL] [Abstract][Full Text] [Related]
17. [Liver transplantation for familial amyloid polyneuropathy]. Adams D; Slama M; Samuel D Presse Med; 2010 Jan; 39(1):17-25. PubMed ID: 19419835 [TBL] [Abstract][Full Text] [Related]
18. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406 [TBL] [Abstract][Full Text] [Related]
19. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Rudolph T; Kurz MW; Farbu E Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975 [TBL] [Abstract][Full Text] [Related]
20. [Transthyretin familial amyloid polyneuropathy]. Kopishinskaya SV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]